| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |